MENU
PDSB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

PDS Biotechnology (PDSB) Earnings Date & Reports

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States... Show more

A.I. Advisor
published Earnings

PDSB is expected to report earnings to rise 50.00% to -31 cents per share on May 14

PDS Biotechnology PDSB Stock Earnings Reports
Q1'25
Est.
$-0.31
Q4'24
Beat
by $0.10
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.10
Q1'24
Beat
by $0.07
The last earnings report on March 27 showed earnings per share of -20 cents, beating the estimate of -30 cents. With 259.13K shares outstanding, the current market capitalization sits at 52.43M.
View a ticker or compare two or three
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of clinical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
303A College Road
Phone
+1 800 208-3343
Employees
25
Web
https://www.pdsbiotech.com